Please use this identifier to cite or link to this item: https://doi.org/10.1007/s13346-012-0067-1
DC FieldValue
dc.titleClinical therapeutics for phenylketonuria
dc.contributor.authorKochhar, J.S.
dc.contributor.authorChan, S.Y.
dc.contributor.authorOng, P.S.
dc.contributor.authorKang, L.
dc.date.accessioned2014-10-29T02:02:51Z
dc.date.available2014-10-29T02:02:51Z
dc.date.issued2012-08
dc.identifier.citationKochhar, J.S., Chan, S.Y., Ong, P.S., Kang, L. (2012-08). Clinical therapeutics for phenylketonuria. Drug Delivery and Translational Research 2 (4) : 223-237. ScholarBank@NUS Repository. https://doi.org/10.1007/s13346-012-0067-1
dc.identifier.issn2190393X
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/106628
dc.description.abstractPhenylketonuria was amongst the first of the metabolic disorders to be characterised, exhibiting an inborn error in phenylalanine metabolism due to a functional deficit of the enzyme phenylalanine hydroxylase. It affects around 700,000 people around the globe. Mutations in the gene coding for hepatic phenylalanine hydroxylase cause this deficiency resulting in elevated plasma phenylalanine concentrations, leading to cognitive impairment, neuromotor disorders and related behavioural symptoms. Inception of low phenylalanine diet in the 1950s marked a revolution in the management of phenylketonuria and has since been a vital element of all therapeutic regimens. However, compliance to dietary therapy has been found difficult and newer supplement approaches are being examined. The current development of gene therapy and enzyme replacement therapeutics may offer promising alternatives for the management of phenylketonuria. This review outlines the pathological basis of phenylketonuria, various treatment regimes, their associated challenges and the future prospects of each approach. Briefly, novel drug delivery systems which can potentially deliver therapeutic strategies in phenylketonuria have been discussed. © 2012 Controlled Release Society.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1007/s13346-012-0067-1
dc.sourceScopus
dc.subjectHyperphenylalaninemia
dc.subjectPhenylalanine
dc.subjectPhenylalanine ammonia lyase
dc.subjectPhenylalanine hydroxylase
dc.subjectPhenylketonuria
dc.typeReview
dc.contributor.departmentPHARMACY
dc.description.doi10.1007/s13346-012-0067-1
dc.description.sourcetitleDrug Delivery and Translational Research
dc.description.volume2
dc.description.issue4
dc.description.page223-237
dc.identifier.isiut000209424000001
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

1
checked on Oct 10, 2019

WEB OF SCIENCETM
Citations

1
checked on Oct 3, 2019

Page view(s)

53
checked on Oct 11, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.